Analyst Ratings for Cardiff Oncology (CRDF)
CRDF Rating Summary
CRDF Price Target Summary
- Highest: $19.00 (Ladenburg Thalmann)
- Lowest: $2.00 (Craig-Hallum)
- Average: $8.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.50 (+620.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$8.50 (+620.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/3/2026 | Craig-Hallum | Albert Lowe | Downgrade | Hold (Buy) |
2.00 (N/A) |
1.51 (1.18) |
-21.85% | Details |
| 6/1/2026 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.90 (1.18) |
-37.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
